Haemonetics (HAE) Net Cash Flow (2009 - 2026)

Haemonetics' Net Cash Flow history runs 18 years deep, the most recent figure standing at -$117.2 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 595.25% year-over-year to -$117.2 million; the TTM figure through Mar 2026 stood at -$64.8 million (down 150.36% YoY), while the FY2026 annual figure was -$64.8 million, down 150.36% from the prior year.
• Net Cash Flow was -$117.2 million for Q1 2026 at Haemonetics, down from $66.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $167.1 million in Q2 2024 to a low of -$160.0 million in Q4 2023.
• Historically, Net Cash Flow has averaged $3.3 million across 5 years, with a median of $3.8 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Net Cash Flow sank 635.35% in 2023, then surged 5077.38% in 2024.
• A 5-year view of Net Cash Flow shows it stood at -$21.8 million in 2022, then tumbled by 635.35% to -$160.0 million in 2023, then soared by 117.35% to $27.8 million in 2024, then surged by 138.1% to $66.1 million in 2025, then tumbled by 277.18% to -$117.2 million in 2026.
• The last three Net Cash Flow figures came in at -$117.2 million (Q1 2026), $66.1 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.